5 foods that can trigger an asthma attack
Struggling with asthma? You might want to check your food labels.

No one really knows exactly what causes asthma. What we do however know is that asthma is a chronic inflammatory disease of the airways. Symptoms can vary from person to person, but one thing is constant: when airways come into contact with an asthma trigger, the airways become inflamed, narrow and fill with mucus.
According to statistics from the Western Cape Government, there was a significant rise in adult asthma in South Africa over the past 25 years.
If you are suffering from asthma, it is important to know that although your symptoms can be easily controlled, an attack may be deadly.....

Read more here: health24.com 

------------------------------------------------------

Racial disparities in childhood asthma linked to residential segregation

Researchers have had trouble explaining why black children are much more likely than other children to suffer from asthma. A new study by Princeton University strongly suggests that much of the answer lies in persistent residential segregation, which traps minority children in unhealthy, polluted neighborhoods.
In the United States, black children are twice as likely as other children to develop asthma. Past research has attributed some of this difference to low birth weight, as black children are also more likely than others to be born at a low weight -- defined as less than 2,500 grams, or about 5.5 pounds -- and low birth weight is a risk factor for developing asthma.....

Read more here: news-medical.net

------------------------------------------------------

Roche unloads some rights to drug hopeful after asthma trial disappointment

ZURICH (Reuters) - Roche is offloading some rights to what was once one of its top drug prospects, lebrikizumab, for payments which could total more than $1 billion after the medicine produced only lacklustre results in an asthma study last year.
The Basel-based drugmaker had said in February 2016 that the monoclonal antibody targeting the so-called Interleukin 13 protein hit its goal in just one of two identical Phase III studies - dashing its hopes that late-stage studies would provide a clear path forward after promising earlier trials.....

Read more here: reuters.com